Glenmark
-
Coronavirus: Glenmark defends pricing of its favipiravir drug, calls it ‘effective treatment option’
Scroll Staff
-
US drug regulator says Glenmark’s Himachal Pradesh unit violates its quality standards
Scroll Staff
-
US drug regulator says Glenmark’s Himachal Pradesh unit violates its quality standards
Scroll Staff